Lenk Robert P 4
4 · PLUS THERAPEUTICS, INC. · Filed May 10, 2024
Insider Transaction Report
Form 4
Lenk Robert P
Director
Transactions
- Purchase
Common Stock
2024-05-08$2.04/sh+4,167$8,501→ 29,327 total - Award
Warrants (Right to buy)
2024-05-08+8,334→ 8,334 totalExercise: $1.79From: 2024-05-08→ Common Stock Warrants (8,334 underlying)
Footnotes (2)
- [F1]The expiration date for 4,167 of the warrants (Series A warrants) is May 8, 2029. The expiration date for the other 4,167 warrants (Series B warrants) is the one-year anniversary of the effectiveness of a registration statement covering the resale of shares of common stock underlying the Series B warrants.
- [F2]Half of the warrants are Series A warrants and the other half are Series B warrants.